These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Upper gastrointestinal complications: the causes, consequences, and clinical outcomes. Am J Manag Care; 2001 Sep; 7(12 Suppl):S397-401. PubMed ID: 11570031 [TBL] [Abstract][Full Text] [Related]
26. Nonsteroidal anti-inflammatory drug-induced gastrointestinal damage. Current insights into patient management. Proceedings of a symposium. June 13, 1987, Washington, D.C. Am J Med; 1988 Feb; 84(2A):1-52. PubMed ID: 3348237 [No Abstract] [Full Text] [Related]
27. [Enteropathy induced by nonsteroid anti-inflammatory drugs]. Karateev AE; Nasonova VA Ter Arkh; 2004; 76(2):79-82. PubMed ID: 15106423 [No Abstract] [Full Text] [Related]
28. The prevention of gastropathy and upper abdominal symptoms caused by nonsteroidal anti-inflammatory drugs. Vakil N Rev Gastroenterol Disord; 2006; 6(4):221-6. PubMed ID: 17224894 [TBL] [Abstract][Full Text] [Related]
29. [Non-narcotic analgesics and gastrointestinal lesions: risk factors, treatment, prevention]. Ivashkin VT; Sheptulin AA; Makar'iants ML Klin Med (Mosk); 2001; 79(3):4-7. PubMed ID: 11490415 [No Abstract] [Full Text] [Related]
30. Balancing risks and benefits of cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs. Scheiman JM Gastroenterol Clin North Am; 2009 Jun; 38(2):305-14. PubMed ID: 19446260 [TBL] [Abstract][Full Text] [Related]
31. Is there a difference between upper gastrointestinal tract bleeding induced by nonsteroidal anti-inflammatory drugs and other causes in elderly patients? Küçükardali Y; Yazgan Y; Danaci M Endoscopy; 2003 Apr; 35(4):370-1; author reply 372-3. PubMed ID: 12664400 [No Abstract] [Full Text] [Related]
32. Physicians' approaches to the use of gastroprotective strategies in low-risk non-steroidal anti-inflammatory drug users. Murthy SK; Kauldher S; Targownik LE Aliment Pharmacol Ther; 2006 May; 23(9):1365-72. PubMed ID: 16629943 [TBL] [Abstract][Full Text] [Related]
33. Meta-analysis of risk of gastrointestinal complications with NSAIDs. Narrative review should have been used. Kaufman DW; Shapiro S BMJ; 1997 Feb; 314(7078):445-6. PubMed ID: 9040416 [No Abstract] [Full Text] [Related]
34. NSAIDs increase risk of gastrointestinal bleeding in primary care patients with dyspepsia. Kurata JH; Nogawa AN; Noritake D J Fam Pract; 1997 Sep; 45(3):227-35. PubMed ID: 9300002 [TBL] [Abstract][Full Text] [Related]
35. NSAID use in populations at-risk for UGI hemorrhage. Sobel ER Del Med J; 1998 Jun; 70(6):299-300. PubMed ID: 9662873 [No Abstract] [Full Text] [Related]
36. [Prevention and treatment of upper gastrointestinal bleeding by nonsteroidal anti-inflammatory drugs]. Bar-Dayan Y; Levi Y Harefuah; 1996 Apr; 130(8):535-7. PubMed ID: 8765878 [No Abstract] [Full Text] [Related]
37. [Prevention of vascular thrombosis and risk of gastrointestinal complications]. Karateev AE; Nasonov EL Ter Arkh; 2007; 79(5):84-9. PubMed ID: 17672083 [No Abstract] [Full Text] [Related]
38. [Aspirin and surgery]. García-Sancho Martín L An R Acad Nac Med (Madr); 1997; 114(4):771-92. PubMed ID: 9616943 [No Abstract] [Full Text] [Related]
39. NSAIDs and the gut--where are we now? Shield M Eur J Rheumatol Inflamm; 1994; 14(3 Suppl):13-23. PubMed ID: 7556341 [No Abstract] [Full Text] [Related]